Literature DB >> 6825561

Theophylline toxicity--a consequence of congestive heart failure.

D F LeGatt.   

Abstract

A case is reported of an elderly patient with congestive heart failure (CHF), who was treated with juvenile oral doses of theophylline (Theo-Dur). The patient experienced toxic symptoms, and plasma concentrations were determined. A value of 60.6 micrograms/ml was reported and the theophylline administration was subsequently discontinued. Plasma concentrations and toxicity of theophylline are unpredictable in patients with CHF because of the great variability in clearance. This case demonstrates the necessity for careful monitoring of theophylline plasma levels in CHF patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825561     DOI: 10.1177/106002808301700119

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  1 in total

1.  Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management.

Authors:  Michael E Hopkins; Robert V MacKenzie-Ross
Journal:  BMC Pharmacol Toxicol       Date:  2016-03-05       Impact factor: 2.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.